Bio Protocol vs Ravencoin — how do they compare? Bio Protocol trades at Rp428.54 (market cap Rp974,32M, Rp148,57M 24h volume), while Ravencoin trades at Rp53.8 (market cap Rp807,02M, Rp80,76M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 16,4B / 21B RVN (79%) for Ravencoin. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Ravencoin for 98 Days on average.
| BIO | RVN | |
|---|---|---|
Market Cap | Rp974,32M | Rp807,02M |
Volume (24h) | Rp148,57M | Rp80,76M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 16,4B / 21B RVN (79%) |
Typical Hold Time | 18 Days | 98 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Ravencoin (RVN) is trading at Rp47.631 with a market cap of Rp775.79M, showing a bearish technical signal overall despite bullish oscillators. The asset is near key support at Rp44-46, with 79% of its 21M max supply in circulation. No major protocol updates or ecosystem news are currently driving momentum, leaving price action heavily influenced by market sentiment and technical levels.
The outlook remains cautious due to strong bearish moving averages and high ADX readings indicating a strong trend. Opportunities exist if support holds, but risks include low liquidity, crypto market volatility, and lack of recent fundamental catalysts. Investors should monitor for breaks below Rp44 for further downside.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Ravencoin (RVN) is a digital peer-to-peer (P2P) network that aims to implement a use case specific blockchain, designed to efficiently handle one specific function: the transfer of assets from one party to another. The release of the Ravencoin mainnet and increase in activity on the platform should help the price. Any news of notable companies or financial institutions utilizing the platform should also have a positive effect.
Read more on RVN →